Top Tweets for #ICECap
#ICECAP (adult version if the P-ICECAP) #TTM #OHCA #PedsICU @JAMA_current
Duration of Therapeutic Hypothermia After Out-of-Hospital Cardiac Arrest https://t.co/zEL0aEdJEm
take me back to yesterday’s sunshine and this ice cap immediately ☀️🥤
#oocosplay #wasiangirl #icecap #rainyday #yesterday
Thanks to all who listened to #ICECAP @SiriusXMNHL throughout the #StanleyCup playoffs.
Never fails to amaze me how many reach out to say what the show means to them.
Alongside @westcoasthkyNHL, @MikeyBonora, @LucasCritelli23, @expomick, it’s a privilege!
Between-hospital variability in outcomes after cardiac arrest in a large clinical trial network. See unadjusted (A) and adjusted (B) survival to discharge from #ICECAP sites. Variability likely worse out of clinical trial sites. @ResusJournal https://t.co/ih4BXgbzS7

#ICECAP is out. This NIH-funded RCT compared different durations of cooling (12-72 hours) after cardiac arrest and found no impact of longer cooling inervals on survival or functional outcome. But there was no arm without TTM at all -- which is what many centers have now reverted to....
#curingcoma
Tonight is a night I am glad I am on the radio.
#ICECAP @SiriusXMNHL at 1am ET to put a wrap on the night in the #StanleyCupPlayoffs
How are you North Carolina after that all time classic?

@withPlanet_asa 世界遺産の大陸氷床へ。氷床とは大地を飲み込むほど巨大な「氷の蓋」のようなもので地球上で南極とここの2カ所しかありません。近くまでUTV(多目的四輪車)で行ったあとは徒歩のみ。スパイクをつけ、凍った川をロープを頼りに渡り、バキバキと響く氷塊を踏み締めて進みます。#Greenland #icecap
Our latest #ICECAP work on role of docetaxel with ADT and RT in high-risk prostate cancer, published now in @EurUrolOncol:
https://t.co/41h6DvWvh4
@DanaFarber_GU @DanaFarberNews @ChrisSweens1 @PCFnews
just pooped at school who is proud of me.... my tummy feels so much better bro @poopyballfart gets the pain #icecap

60 days of #StanleyCup playoffs. The story is always the games & it is an honor to help tell it @SiriusXMNHL
To everyone who listened along the way, myself, @westcoasthky, @MikeyBonora, @expomick & @PBerce thank you for having us on.
#ICECAP signing off. Enjoy the offseason!
Only once in NHL history has the first three games of the Stanley Cup final all gone to OT, back in 1951 (Habs-Leafs). Can Oilers-Panthers join that historical mark tonight? With an 8:20 pm ET puck drop and a post-game column to write, I'm hoping not !
Docetaxel with ADT and radiotherapy for high-risk localized #ProstateCancer: An #ICECaP IPD meta-analysis of randomized controlled trials. Presentation by @PrafulRavi1 @DanaFarber. #ASCO25 written coverage by @zklaassen_md @GACancerCenter > https://t.co/kqbT4Bnr6Q @ASCO

@PrafulRavi1 #ICECAP meta-analysis shows addition of docetaxel to RT + long-term ADT in high-risk localized #prostatecancer does not significantly improve OS and MFS, modest benefits in EFS/PCSM
#ASCO25
@OncoAlert

🗣️Prostate Rapid Oral Abstract #ASCO25
👉Abt5013: Dr @PrafulRavi1 presenting Docetaxel + ADT + XRTR for high risk localized PC (HRLPC) using individual patient data from #ICECAP
n = 1690 from 4RCTs
High-risk: 1 RF (Gleason ≥8, PSA >20, ≥cT3)
Very high-risk: 2-3 RFs and/or cN1 disease.
median F/u 10 years
👉Patient Characteristics
Median age = 65
median PSA = 23 (IQR 10-48)
cN1 disease = 154 (9%)
LTADT + RT = 1444 (85%)
👉Outcomes in all HRLPC
♦️MFS (HR=0.89 [0.76-1.05], p=0.160)
♦️OS (HR=0.88 [0.74-1.05], p=0.167)
👉Outcomes in Subgroups
Very High Risk (n=1054)
♦️MFS (HR=0.86 [0.71-1.05])
♦️OS (HR=0.85 [0.68-1.07])
High Risk (n=636)
♦️MFS (HR=0.97 [0.74-1.27])
♦️OS (HR=0.95 [0.71-1.28])
🔑 KEY TAKE AWAYS
- Some HRLPC pts with very high-risk disease may benefit from the addition of docetaxel to RT+ADT.
👥 @neerajaiims @Silke_Gillessen @APCCC_Lugano @Prof_Nick_James @CParkMD @ChrisSweens1 @AtishChoudhury @TDorffOnc @DrSpratticus @Soum_Roy_RadOnc @CaPsurvivorship @bavilima @DRBakaloudiMD @nataliagandur @bergsa83 @OncoAlert @OncBrothers @urotoday @Uromigos @DanaFarber_GU @DanaFarber
![MikeSerzanMD's tweet photo. 🗣️Prostate Rapid Oral Abstract #ASCO25
👉Abt5013: Dr @PrafulRavi1 presenting Docetaxel + ADT + XRTR for high risk localized PC (HRLPC) using individual patient data from #ICECAP
n = 1690 from 4RCTs
High-risk: 1 RF (Gleason ≥8, PSA >20, ≥cT3)
Very high-risk: 2-3 RFs and/or cN1 disease.
median F/u 10 years
👉Patient Characteristics
Median age = 65
median PSA = 23 (IQR 10-48)
cN1 disease = 154 (9%)
LTADT + RT = 1444 (85%)
👉Outcomes in all HRLPC
♦️MFS (HR=0.89 [0.76-1.05], p=0.160)
♦️OS (HR=0.88 [0.74-1.05], p=0.167)
👉Outcomes in Subgroups
Very High Risk (n=1054)
♦️MFS (HR=0.86 [0.71-1.05])
♦️OS (HR=0.85 [0.68-1.07])
High Risk (n=636)
♦️MFS (HR=0.97 [0.74-1.27])
♦️OS (HR=0.95 [0.71-1.28])
🔑 KEY TAKE AWAYS
- Some HRLPC pts with very high-risk disease may benefit from the addition of docetaxel to RT+ADT.
👥 @neerajaiims @Silke_Gillessen @APCCC_Lugano @Prof_Nick_James @CParkMD @ChrisSweens1 @AtishChoudhury @TDorffOnc @DrSpratticus @Soum_Roy_RadOnc @CaPsurvivorship @bavilima @DRBakaloudiMD @nataliagandur @bergsa83 @OncoAlert @OncBrothers @urotoday @Uromigos @DanaFarber_GU @DanaFarber](https://pbs.twimg.com/media/GsY5jYxXUAA7qYj.jpg)
Docetaxel with ADT and radiotherapy for high-risk localized #ProstateCancer: an #ICECaP individual patient-data meta-analysis of randomized controlled trials. Presentation by @PrafulRavi1 @DanaFarber. #ASCO25 written coverage by @zklaassen_md @GACancerCenter > https://t.co/FpyBihunmW @ASCO

Dallas’ Jamie Benn has been fined $5,000, the maximum allowable under the CBA, for roughing Winnipeg’s Mark Scheifele late in Thursday night’s game.
The first #StanleyCupPlayoffs edition of #ICECAP goes with me and @MikeyBonora at 1am ET on @SiriusXMNHL
https://t.co/t3dnhQRhlb
Last Seen Hashtags on Sotwe
criollodesafio
Seen from Colombia
minichat(****************) filter:native_video
Seen from Brazil
เชียงรายรับงาน
Seen from Thailand
minichat #snapchat #minichat filter:native_video since:2026-09-20
Seen from Peru
หนังเอ็กดูฟรี
Seen from Thailand
南昌
Seen from Korea
女初
lina
Seen from United States
cuminthroat
minichat ((((((()))))))*filter:videos
Seen from Brazil
Most Popular Users

Elon Musk 
@elonmusk
241.7M followers

Barack Obama 
@barackobama
119M followers

Cristiano Ronaldo 
@cristiano
114.4M followers

Donald J. Trump 
@realdonaldtrump
111.9M followers

Narendra Modi 
@narendramodi
107.2M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.4M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
90M followers

Taylor Swift 
@taylorswift13
83.9M followers

Lady Gaga 
@ladygaga
75.4M followers

Virat Kohli 
@imvkohli
73.4M followers

Kim Kardashian 
@kimkardashian
70.9M followers

YouTube 
@youtube
68.8M followers

Neymar Jr 
@neymarjr
66.4M followers

Bill Gates 
@billgates
65.2M followers

Selena Gomez 
@selenagomez
63.1M followers

The Ellen Show
@theellenshow
62.3M followers

CNN 
@cnn
61.8M followers

X 
@x
60.7M followers
























![MikeSerzanMD's tweet photo. 🗣️Prostate Rapid Oral Abstract #ASCO25
👉Abt5013: Dr @PrafulRavi1 presenting Docetaxel + ADT + XRTR for high risk localized PC (HRLPC) using individual patient data from #ICECAP
n = 1690 from 4RCTs
High-risk: 1 RF (Gleason ≥8, PSA >20, ≥cT3)
Very high-risk: 2-3 RFs and/or cN1 disease.
median F/u 10 years
👉Patient Characteristics
Median age = 65
median PSA = 23 (IQR 10-48)
cN1 disease = 154 (9%)
LTADT + RT = 1444 (85%)
👉Outcomes in all HRLPC
♦️MFS (HR=0.89 [0.76-1.05], p=0.160)
♦️OS (HR=0.88 [0.74-1.05], p=0.167)
👉Outcomes in Subgroups
Very High Risk (n=1054)
♦️MFS (HR=0.86 [0.71-1.05])
♦️OS (HR=0.85 [0.68-1.07])
High Risk (n=636)
♦️MFS (HR=0.97 [0.74-1.27])
♦️OS (HR=0.95 [0.71-1.28])
🔑 KEY TAKE AWAYS
- Some HRLPC pts with very high-risk disease may benefit from the addition of docetaxel to RT+ADT.
👥 @neerajaiims @Silke_Gillessen @APCCC_Lugano @Prof_Nick_James @CParkMD @ChrisSweens1 @AtishChoudhury @TDorffOnc @DrSpratticus @Soum_Roy_RadOnc @CaPsurvivorship @bavilima @DRBakaloudiMD @nataliagandur @bergsa83 @OncoAlert @OncBrothers @urotoday @Uromigos @DanaFarber_GU @DanaFarber](https://pbs.twimg.com/media/GsY5igsWAAAiz_B.jpg)
![MikeSerzanMD's tweet photo. 🗣️Prostate Rapid Oral Abstract #ASCO25
👉Abt5013: Dr @PrafulRavi1 presenting Docetaxel + ADT + XRTR for high risk localized PC (HRLPC) using individual patient data from #ICECAP
n = 1690 from 4RCTs
High-risk: 1 RF (Gleason ≥8, PSA >20, ≥cT3)
Very high-risk: 2-3 RFs and/or cN1 disease.
median F/u 10 years
👉Patient Characteristics
Median age = 65
median PSA = 23 (IQR 10-48)
cN1 disease = 154 (9%)
LTADT + RT = 1444 (85%)
👉Outcomes in all HRLPC
♦️MFS (HR=0.89 [0.76-1.05], p=0.160)
♦️OS (HR=0.88 [0.74-1.05], p=0.167)
👉Outcomes in Subgroups
Very High Risk (n=1054)
♦️MFS (HR=0.86 [0.71-1.05])
♦️OS (HR=0.85 [0.68-1.07])
High Risk (n=636)
♦️MFS (HR=0.97 [0.74-1.27])
♦️OS (HR=0.95 [0.71-1.28])
🔑 KEY TAKE AWAYS
- Some HRLPC pts with very high-risk disease may benefit from the addition of docetaxel to RT+ADT.
👥 @neerajaiims @Silke_Gillessen @APCCC_Lugano @Prof_Nick_James @CParkMD @ChrisSweens1 @AtishChoudhury @TDorffOnc @DrSpratticus @Soum_Roy_RadOnc @CaPsurvivorship @bavilima @DRBakaloudiMD @nataliagandur @bergsa83 @OncoAlert @OncBrothers @urotoday @Uromigos @DanaFarber_GU @DanaFarber](https://pbs.twimg.com/media/GsY5gyPWAAAlpk-.jpg)
![MikeSerzanMD's tweet photo. 🗣️Prostate Rapid Oral Abstract #ASCO25
👉Abt5013: Dr @PrafulRavi1 presenting Docetaxel + ADT + XRTR for high risk localized PC (HRLPC) using individual patient data from #ICECAP
n = 1690 from 4RCTs
High-risk: 1 RF (Gleason ≥8, PSA >20, ≥cT3)
Very high-risk: 2-3 RFs and/or cN1 disease.
median F/u 10 years
👉Patient Characteristics
Median age = 65
median PSA = 23 (IQR 10-48)
cN1 disease = 154 (9%)
LTADT + RT = 1444 (85%)
👉Outcomes in all HRLPC
♦️MFS (HR=0.89 [0.76-1.05], p=0.160)
♦️OS (HR=0.88 [0.74-1.05], p=0.167)
👉Outcomes in Subgroups
Very High Risk (n=1054)
♦️MFS (HR=0.86 [0.71-1.05])
♦️OS (HR=0.85 [0.68-1.07])
High Risk (n=636)
♦️MFS (HR=0.97 [0.74-1.27])
♦️OS (HR=0.95 [0.71-1.28])
🔑 KEY TAKE AWAYS
- Some HRLPC pts with very high-risk disease may benefit from the addition of docetaxel to RT+ADT.
👥 @neerajaiims @Silke_Gillessen @APCCC_Lugano @Prof_Nick_James @CParkMD @ChrisSweens1 @AtishChoudhury @TDorffOnc @DrSpratticus @Soum_Roy_RadOnc @CaPsurvivorship @bavilima @DRBakaloudiMD @nataliagandur @bergsa83 @OncoAlert @OncBrothers @urotoday @Uromigos @DanaFarber_GU @DanaFarber](https://pbs.twimg.com/media/GsY5ft7WsAAACrf.jpg)
